摘要
现代专利保护对以传统药物为基础的植物药产业的可持续发展和国际化有着深刻的影响。我国中药大部分可归为植物药范畴,但目前中药企业应用专利保护制度的能力还较为薄弱。分析中国、日本、韩国、美国、欧盟、印度等国家和地区针对植物药专利在其母国的申请情况、在中国的申请情况以及向外申请情况。同时,结合我国重点中药企业在欧美的专利布局提出建议,以期加强企业对于中药知识产权的保护意识,重视全球布局。
Patent protection system has a profound impact on the sustainable development and internationalization of herbal drugs based on the traditional medicine.However,the ability of Chinese enterprises in applying the current system of patent protection is still weak.In this article,the patent application situation for herbal drugs is analyzed and compared,by using the data of China,Japan,Republic of Korea,the United States,European Union and India,based on their domestic patent applications,Chinese patent applications and the foreign patent applications.In the meantime,combined with patent port-folio of key Chinese medicine enterprises in Europe and US,this article also gives some suggestions for strengthening the awareness of intellectual property protection of traditional Chinese medicine and the global layout.
出处
《科技管理研究》
CSSCI
北大核心
2014年第16期156-161,共6页
Science and Technology Management Research
基金
中央高校基本科研业务费项目"中药科技与中药国际保护和推广研究"(WT1221002)
关键词
植物药
中药
专利保护
专利布局
botanical drug
Chinese traditional medicine
patent protection
patent portfolio
